The Usefulness of Combining Noninvasive Methods for Early Identification and Potential Prevention of Cystic Fibrosis-Associated Liver Disease

Cystic fibrosis-associated liver disease is the third leading cause of morbidity and mortality in patients with cystic fibrosis (CF). Liver damage in the course of CF ranges from biochemical abnormalities to full-blown cirrhosis and may involve complicated processes like inflammation, fibrogenesis,...

Descripción completa

Detalles Bibliográficos
Autores principales: Shukla, Twisha S, Gutlapalli, Sai Dheeraj, Farhat, Hadi, Irfan, Huma, Muthiah, Kanmani, Pallipamu, Namratha, Taheri, Sogand, Thiagaraj, Suvedha S, Hamid, Pousette
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Cureus 2022
Materias:
Pediatrics
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9826601/
https://www.ncbi.nlm.nih.gov/pubmed/36628032
http://dx.doi.org/10.7759/cureus.32340

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9826601/
https://www.ncbi.nlm.nih.gov/pubmed/36628032
http://dx.doi.org/10.7759/cureus.32340

Ejemplares similares